What was Lukas biomedical Inc.’s price range in the past 12 months?
Lukas biomedical Inc. lowest stock price was TWD 16.85 and its highest was TWD 32.50 in the past 12 months.
What is Lukas biomedical Inc.’s market cap?
Lukas biomedical Inc.’s market cap is TWD 749.55M.
When is Lukas biomedical Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Lukas biomedical Inc. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Lukas biomedical Inc. pay dividends?
Lukas biomedical Inc. does not currently pay dividends.
What is Lukas biomedical Inc.’s EPS estimate?
Lukas biomedical Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lukas biomedical Inc. have?
Lukas biomedical Inc. has 41,874,370 shares outstanding.
Which hedge fund is a major shareholder of Lukas biomedical Inc.?
Currently, no hedge funds are holding shares in TW:6814
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lukas biomedical Inc.
Founded in 2002 and headquartered in New Taipei, Taiwan, Lukas Biomedical Inc. primarily develops immune cell medical technologies. These innovations are utilized for regenerative medicine and as complementary treatments for cancer. The company's operations are segmented into four distinct areas: E-commerce, Medical Management Business, Cell Product, and Pharmaceutical Market. Furthermore, it diversifies its business by wholesaling and retailing cosmetics, alongside providing housing equipment rental services.